Skip to main content

RAD April 2023 Conference Abstracts and Posters

All accepted abstracts have been published in The British Journal of Dermatology, Volume 188, Issue Supplement 3, June 2023. You may access the publication at:

#365 - Phase 2 Trial in Progress — Lirentelimab in Adults with Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments

Cristian Rodriguez, Anesa Moyer, Alan T. Chang, Enoch Bortey, Craig Paterson

#368 - Impact of a digital atopic dermatitis educational intervention on hispanic patients and family members

Luis F. Andrade , MaryJo Bekhash, Siri Choragudi, Juan M Gonzalez, Rodrigo Valdes, Gil Yosipovitch

#372 - Early insights into the characteristics of tralokinumab patients in a real-world setting in the United States

Raj Chovatiya, Sanjeev Balu, Yestle Kim, Amanda G. Althoff, Lawrence Rasouliyan

#373 - Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from 8 trials

Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen, Melinda Gooderham, Vivian Laquer, Chitra R. Natalie, Fangyi Zhao, Eric Meskimen, Hany ElMaraghy, Sonia Montmayeur, Gemma Jimenez, Marjolein de Bruin-Weller

#374 - Shared decision making for eczema patients and caregivers is not dependent on length of relationship with a provider or provider specialty

Allison R. Loiselle, Isabelle Thibau, Jessica K. Johnson, Wendy Smith Begolka

#375 - Understanding the effectiveness, utilization, and perceptions of action plans in adults and caregivers of children with atopic dermatitis

Jessica K. Johnson, Allison R. Loiselle, Wendy Smith Begolka

#377 - Real-world use of OPZELURA™: safety analysis at 1 year

Wilson Hu, Michele Thornton, Robert A. Livingston

#380 - Patients maintain stable response with no or minimal fluctuations during treatment with lebrikizumab up to week 52

Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, Peter Lio, Jose Manuel Carrascosa, Gaia Gallo, Marta Casillas, Yuxin Ding, Sherry Chen, Helena Agell, Jacob P. Thyssen

#381 - Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis

Jenny E. Murase, Raj Chovatiya, Lindsay Strowd, Jacob P. Thyssen, Christine Bangert, Amber Reck Atwater, Gaia Gallo, Laia Bardolet, Fan Yang, Jinglin Zhong, Delphine Staumont-Sallé

#382 - Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab

Linda Stein Gold, Jan Gutermuth, David N. Adam, Carsten Flohr, Stephan Weidinger, Amber Reck Atwater, Evangeline Pierce, Fan Emily Yang, Sherry Chen, Ignasi Pau-Charles, Lisa A. Beck

Page 1 of 6
Results 1 - 10 of 60